Offer - Urjas Oil for just ₹ 1 X
Thyromed 125 Mcg Tablet is a prescription medicine that is available as a Tablet. It is primarily used for the treatment of Hypothyroidism. Other than this, Thyromed 125 Mcg Tablet has some other therapeutic uses, which have been discussed ahead.
The right dosage of Thyromed 125 Mcg Tablet depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
While these are the most often observed Thyromed 125 Mcg Tablet side effects, there are can be others also. These have been listed below. Such side effects of Thyromed 125 Mcg Tablet normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
In addition, Thyromed 125 Mcg Tablet's effect is Safe during pregnancy and Mild for lactating mothers. In addition, Thyromed 125 Mcg Tablet's effects on the liver, heart and kidney are discussed below in the Thyromed 125 Mcg Tablet related warnings section.
Individuals suffering from medical conditions like Heart Disease, Hypopituitarism must refrain from the use of Thyromed 125 Mcg Tablet since this can cause severe adverse effects. Other conditions have been mentioned below in the Thyromed 125 Mcg Tablet contraindications section.
Drug reaction of Thyromed 125 Mcg Tablet with other medicines has been reported. See below for a complete list.
In addition to these precautions, you may also note that Thyromed 125 Mcg Tablet is safe while driving, and is is addictive in nature.
Thyromed 125 Mcg Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Infant (1 month to 2 years) |
|
Neonates (0 to 1 month) |
|
Is the use of Thyromed 125 Mcg Tablet safe for pregnant women?
Pregnant women can take Thyromed safely.
Is the use of Thyromed 125 Mcg Tablet safe during breastfeeding?
Side effects of Thyromed for breastfeeding are little to none, so you can take it without doctor's advice.
What is the effect of Thyromed 125 Mcg Tablet on the Kidneys?
Thyromed is completely safe for kidneys.
What is the effect of Thyromed 125 Mcg Tablet on the Liver?
Using Thyromed does not have any harmful effects on the liver.
What is the effect of Thyromed 125 Mcg Tablet on the Heart?
Thyromed is not harmful for the heart.
If you are suffering from any of the following diseases, you should not take Thyromed 125 Mcg Tablet unless your doctor advises you to do so -
Is this Thyromed 125 Mcg Tablet habit forming or addictive?
No, there is no any evidence that Thyromed 125 Mcg Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Thyromed 125 Mcg Tablet will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Yes, Thyromed 125 Mcg Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Thyromed 125 Mcg Tablet for mental disorders.
Interaction between Food and Thyromed 125 Mcg Tablet
Taking Thyromed 125 Mcg Tablet with food is safe.
Interaction between Alcohol and Thyromed 125 Mcg Tablet
No research has been done on this till date. Therefore, it is not known what the effect of taking Thyromed 125 Mcg Tablet with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Levoxyl (levothyroxine sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 769-770